Strengthening Internal Controls for Meals and Hospitality Policies in Medical Manufacturing

Medical manufacturing requires robust internal controls to prevent meals and hospitality from creating compliance risks and harming the company’s reputation. Organizations must adhere to the regulatory frameworks of the Anti-Kickback Statute (AKS), Foreign Corrupt Practices Act (FCPA), and the Corruption of Foreign Public Officials Act (CFPOA), among others. With medical companies pushing the boundaries of innovation with emerging technologies, companies must ensure their compliance programs keep pace.

Internal controls must remain a priority to ensure adherence to all regulations that govern the healthcare industry. An effective monitoring program combined with proper training can prevent and detect inappropriate transfers of value, which helps companies maintain their compliance and prevent unwanted audits or costly scandals.

Key Regulations

• Anti-Kickback Statute: U.S. law that prohibits the exchange of anything of value to induce or reward referrals for services or items reimbursed by federal health care programs like Medicare and Medicaid.
• Foreign Corrupt Practices Act: U.S. law prohibiting citizens and organizations from bribing foreign government officials to obtain or safeguard their business.
• Corruption of Foreign Public Officials Act (CFPOA): Preventing corruption of foreign public officials related to international business transactions in Canada.
• Open Payments: Enforcing that manufacturers remain transparent regarding payments and transfers of value provided to reportable U.S. healthcare professionals.

Additionally, there’s ethical guidance for industry-standard medical technology companies to follow, such as:

• AdvaMed Code: Guiding ethical interactions with healthcare professionals.
• MedTech Europe: Ethical guidelines for industry professionals to adhere to when working with healthcare professionals.

The Risks of Gifts & Hospitality

The solicitation, facilitation, or even agreement to provide an inappropriate transfer of value can result in severe negative backlash and fines. Members of the public, investors, and regulators view wrongdoing in this area as a type of fraud, which can result in various potential consequences, such as:

• Criminal and Civil Penalties, including:
  • Prison sentences
  • Forfeiture of assets gained through kickback schemes
• Reputational damage:
  • Loss of trust with the public, other healthcare providers, healthcare organizations, and investors.

Case Study: Medtronic

Medtronic was required to pay an $8.1 million settlement to resolve allegations it violated the False Claims Act by paying kickbacks to induce a South Dakota neurosurgeon to use some of its products. It was discovered that Medtronic employees covered the cost of over 100 events at a restaurant owned by the South Dakota neurosurgeon. These social gatherings were for the medical professional’s friends and business partners.

Case Study: Abiomed

Abiomed was required to pay a $3.1 million settlement to resolve similar allegations that it violated the False Claims Act by purchasing lavish meals for physicians in order to induce them to use Abiomed’s Impella line of heart pumps. Abiomed employees paid for expensive meals, excessive alcohol, and allowed customer spouses to attend the business meetings and educational events.

Best Practices for Strengthening Internal Controls

Medical manufacturers seeking to strengthen their internal systems to ensure compliance can implement several strategies to help them achieve this goal.

Policy Design

• Limits: Implement clear monetary limits and guidelines for providing meals and hospitality. When establishing guidelines, consider local laws and regulations, as well as regional standards of reasonableness and propriety.
• Pre-Approval Process: Establish a streamlined, intuitive pre-approval process for hospitality related to travel that empowers business teams to act efficiently while ensuring robust compliance oversight.

Training, Monitoring & Reporting

• Employee Training: Proactively train employees on potential real-world scenarios. This helps to reinforce your policy expectations differently than simply asking someone to read a policy manual. It helps employees to understand how policies should be applied in practice and reinforces company expectations.
• Automated Compliance Monitoring: Utilize tools that leverage advanced analytics and machine learning to provide your compliance team with real-time visibility into financial and operational data. This enables you to detect potential misconduct or mitigate failures as they happen—not months later. This shifts your program from reactive audits to proactive risk management.
• Robust Reporting Avenues: Provide multi-channel (e.g., online, phone, etc.) avenues for employees to report wrongdoing and efficient case management solutions that allow your internal team to manage investigations as efficiently as possible.

Closing Thoughts

Medical manufacturers navigate an increasingly complex regulatory environment, and the stakes for having ethical behavior and robust internal controls have never been higher. Guidelines around interactions with healthcare professionals and their employers are not just boxes to check, but also critical safeguards in protecting patient trust, corporate reputations, and the integrity of innovative healthcare.

By embedding a culture of compliance and harnessing advanced technology to proactively monitor potential risks, medical manufacturers can mitigate potential problems in real-time. Investing in these digital frameworks now ensures not only alignment with global regulatory standards but also builds operational resilience and trust for the future.

Brook Mishler, RN, MSN, has a rare and dynamic background, beginning as a licensed healthcare professional in acute care before transitioning to medical device clinical support, sales, and training. Through these roles, she developed a deep understanding of how ethics and compliance are woven into daily interactions within the highly regulated life sciences industry. Building on this foundation, Mishler became a highly respected compliance officer, leveraging her firsthand field experience to design practical, business-aligned compliance programs. She is currently the global director of Compliance Solutions—Life Sciences at Case IQ. She is passionate about helping her peers navigate business process challenges by creating solutions that benefit both operational goals and legal and compliance teams.